Funder: National Institutes of Health
Due Dates: June 5, 2025 (New R01) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New R01) | November 5, 2025 (Renewal/Resubmission/Revision) | Additional standard NIH R01 dates through January 2028
Funding Amounts: Estimated 5–8 awards; total of $2.5M in FY25; budgets not limited but must reflect actual needs; max project period 5 years.
Summary: Supports innovative, high-quality nonmalignant hematology research in basic and early translational science aligned with NIDDK, NIA, and NHLBI missions; clinical trials are not allowed.
Key Information: Applicants requesting ≥$500,000 direct costs in any year must contact a program officer at least 6 weeks before submission.